28 March 2024

Scleroderma

Should we be using palliative care for scleroderma?

25 May 2023

Lupus Scleroderma

Now it’s scleroderma’s turn for CAR T

15 December 2022

Apps Scleroderma

ACR highlights: spondyloarthritis and psoriatic arthritis 

8 December 2022

Ankylosing Spondylitis Biosimilars Scleroderma Spondyloarthritis

Good news: you’re trusted

15 November 2022

Scleroderma

Another option for PsA

14 November 2022

Apps Corticosteroids Scleroderma

Highlights of ACR Day 2

6 October 2022

Case study Polymyalgia Rheumatica Scleroderma

One size does not fit all

25 August 2022

cardiovascular Conditions Scleroderma

Promising secukinumab results in children

4 August 2022

Pharmaceuticals Scleroderma

Risankizumab can be used in patients with Crohn’s

16 June 2022

COVID-19 Lupus Scleroderma Spondyloarthritis

Rituximab and non-white ethnicity linked with worse covid outcomes

26 April 2022

Lupus PBS Psoriatic Athritis Scleroderma Spondyloarthritis

PBS biologics approval shakeup on the way

13 April 2022

Scleroderma TNF

Patients and clinicians can agree on PsA disease activity

31 March 2022

Psychology Scleroderma

Psoriasis depression risk dangerously high, and even worse for PsA

10 March 2022

Ankylosing Spondylitis osteomyelitis Scleroderma

The needle moves on adding more to MTX in PsA

3 February 2022

COVID-19 Gout Lupus Scleroderma

Updated covid treatment guidelines and immunosuppressed patients

9 December 2021

Biologics Scleroderma

Promising findings for PsA treatments